The agreement closes a cross-border patent fight over mRNA vaccine technology that had added to a broader web of litigation in the sector. The settlement covers Moderna's COVID-19 shots Spikevax ...
GSK (GSK) stock is trading at GBX1,846.00, marking a daily decline of 2.33%. The price currently sits below its major moving averages, reflecting ongoing pressure in the ...
GSK plc (GSK) fell 2.01% as intraday selling pressured the shares, with buyers unable to sustain early gains amid cautious sentiment and fading momentum. The move is limited by the stock holding ...
GSK (GSK) stock is trading at GBX1,892.50 with a slight gain for the session. The price currently sits above its key short- and medium-term moving averages, suggesting ...
GSK plc (GSK) advanced 1.59% on strong short- and medium-term technical momentum, as buyers drove the stock toward session highs. The move is supported by the price crossing above both the 20-day ...
GSK (GSK) stock is trading at GBX1,836.50, reflecting a modest intraday rise. The price remains below its key moving averages, indicating pressure relative to recent ...
GSK (GSK) stock is trading at GBX1,837 after a modest move lower today. The price sits above its key short-term moving averages but remains beneath the medium- and ...
GSK plc (GSK) surged 2.29% after its third-quarter 2026 results pointed to steady sales growth and maintained earnings guidance, fueling renewed buying interest in the shares. The move finds ...
GSK (GSK) stock is trading at GBX1,838.50, up 1.35% on the day. The price is positioned above its key short-term moving averages but remains below medium- and ...
GSK plc (GSK) slid 1.5% after reporting third-quarter earnings including steady sales growth and reaffirmed full-year guidance, with sellers dominating early trade. The decline is supported by the ...
GSK (GSK) stock is trading at GBX1,801.50, down 1.15% on the day. The price remains below its key moving averages, pointing to ongoing weakness in the current ...
London equities are trading cautiously on Wednesday as investors assess corporate earnings and await the UK budget and the U.S. Federal Reserve's rate decision. The FTSE 100 is down 0.3% by ...
GSK plc (GSK) slumped 4.22% today after a downside gap, even as the company delivered solid third-quarter results and raised its dividend. The move is supported by a bearish technical structure, ...
GSK (GSK) stock is trading at GBX1,911.50 after a modest slip in the latest session, exhibiting a slight decline for the day. The current price sits above its short- and ...
GSK (GSK) stock is trading at GBX1,909.50, up modestly for the session. The price currently sits above its key short- and medium-term moving averages, suggesting a ...
GSK plc (GSK) fell 1.59% after a day marked by profit pressure, as the company reported higher revenue but saw its net margin sharply reduced. The move is further supported by the technical ...
GSK (GSK) stock is trading at GBX1,890, posting a daily loss of 1.41%. Shares are positioned above their key short- and medium-term moving averages while remaining below ...
GSK plc (GSK) advanced 1.63% after receiving US regulatory approval for its cancer drug Jemperli, which drew renewed buyer interest into the session. The up move is supported by technical momentum ...
GSK (GSK) stock is trading at GBX1,873 after a modest pullback in today’s session. The price remains above its short- and medium-term moving averages while holding ...